{"id":"https://openalex.org/W7129611348","doi":"https://doi.org/10.1158/1557-3265.sabcs25-ps4-01-11","title":"Abstract PS4-01-11: Exploration of racial differences in variants of uncertain significance (VUS), ESR1 and PIK3CA mutation frequency, matched therapy use, and outcomes in metastatic breast cancer (mBC)","display_name":"Abstract PS4-01-11: Exploration of racial differences in variants of uncertain significance (VUS), ESR1 and PIK3CA mutation frequency, matched therapy use, and outcomes in metastatic breast cancer (mBC)","publication_year":2026,"publication_date":"2026-02-17","ids":{"openalex":"https://openalex.org/W7129611348","doi":"https://doi.org/10.1158/1557-3265.sabcs25-ps4-01-11"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.sabcs25-ps4-01-11","doi":"https://doi.org/10.1158/1557-3265.sabcs25-ps4-01-11","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs25-ps4-01-11","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5126219760","display_name":"A. A. Davis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. A. Davis","raw_affiliation_strings":["1Department of Medicine, Washington University in St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medicine, Washington University in St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126203079","display_name":"L. S. Welch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100465","display_name":"Guardant (United States)","ror":"https://ror.org/013z4s422","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100465"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. S. Welch","raw_affiliation_strings":["2Medical Affairs, Guardant Health, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Medical Affairs, Guardant Health, Palo Alto, CA","institution_ids":["https://openalex.org/I4210100465"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058075256","display_name":"Jayati Saha","orcid":"https://orcid.org/0000-0003-2613-9441","observed_orcids":["https://orcid.org/0000-0003-2613-9441"]},"institutions":[{"id":"https://openalex.org/I4210100465","display_name":"Guardant (United States)","ror":"https://ror.org/013z4s422","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100465"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Saha","raw_affiliation_strings":["3Outcomes and Evidence, Guardant Health, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Outcomes and Evidence, Guardant Health, Palo Alto, CA","institution_ids":["https://openalex.org/I4210100465"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046785067","display_name":"Leslie Bucheit","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100465","display_name":"Guardant (United States)","ror":"https://ror.org/013z4s422","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100465"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Bucheit","raw_affiliation_strings":["2Medical Affairs, Guardant Health, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Medical Affairs, Guardant Health, Palo Alto, CA","institution_ids":["https://openalex.org/I4210100465"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038662469","display_name":"M. Lipsyc-Sharf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2799798094","display_name":"UCLA Health","ror":"https://ror.org/01d88se56","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. D. Lipsyc-Sharf","raw_affiliation_strings":["4Department of Medicine, Division of Hematology/Oncology, UCLA Health, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Medicine, Division of Hematology/Oncology, UCLA Health, Santa Monica, CA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034972183","display_name":"Aditya Bardia","orcid":"https://orcid.org/0000-0003-4885-1157","observed_orcids":["https://orcid.org/0000-0003-4885-1157"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2799798094","display_name":"UCLA Health","ror":"https://ror.org/01d88se56","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Bardia","raw_affiliation_strings":["4Department of Medicine, Division of Hematology/Oncology, UCLA Health, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Medicine, Division of Hematology/Oncology, UCLA Health, Santa Monica, CA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126257563","display_name":"C. X. Ma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. X. Ma","raw_affiliation_strings":["1Department of Medicine, Washington University in St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medicine, Washington University in St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126238378","display_name":"Massimo Cristofanilli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Cristofanilli","raw_affiliation_strings":["5Department of Medicine, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Medicine, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067366716","display_name":"Emily L. Podany","orcid":"https://orcid.org/0000-0002-9700-3616","observed_orcids":["https://orcid.org/0000-0002-9700-3616"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. L. Podany","raw_affiliation_strings":["1Department of Medicine, Washington University in St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medicine, Washington University in St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"4_Supplement","first_page":"PS4","last_page":"01"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.6464999914169312,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.6464999914169312,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.29829999804496765,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.02759999968111515,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8659999966621399},{"id":"https://openalex.org/keywords/racial-disparities","display_name":"racial disparities","score":0.8500000238418579},{"id":"https://openalex.org/keywords/variants-of-uncertain-significance","display_name":"variants of uncertain significance","score":0.9419999718666077},{"id":"https://openalex.org/keywords/esr1-mutations","display_name":"ESR1 mutations","score":0.949999988079071},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.9879999756813049},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9390000104904175},{"id":"https://openalex.org/keywords/elacestrant","display_name":"elacestrant","score":0.734000027179718},{"id":"https://openalex.org/keywords/alpelisib","display_name":"alpelisib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6480000019073486},{"id":"https://openalex.org/keywords/black-patients","display_name":"Black patients","score":0.8759999871253967},{"id":"https://openalex.org/keywords/black-white-disparities","display_name":"black-white disparities","score":0.46799999475479126},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.515999972820282},{"id":"https://openalex.org/keywords/time-to-treatment-discontinuation","display_name":"time to treatment discontinuation","score":0.8169999718666077},{"id":"https://openalex.org/keywords/time-to-next-treatment","display_name":"time to next treatment","score":0.8259999752044678},{"id":"https://openalex.org/keywords/social-determinants-of-health","display_name":"social determinants of health","score":0.6510000228881836},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.4779999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7559000253677368},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.7519999742507935},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6642000079154968},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6463000178337097},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6334999799728394},{"id":"https://openalex.org/C2993757694","wikidata":"https://www.wikidata.org/wiki/Q3254959","display_name":"Racial differences","level":3,"score":0.44780001044273376},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.44200000166893005},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.427700012922287},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.421999990940094},{"id":"https://openalex.org/C63363279","wikidata":"https://www.wikidata.org/wiki/Q5133848","display_name":"Clinical significance","level":2,"score":0.38519999384880066},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.3580999970436096},{"id":"https://openalex.org/C76509639","wikidata":"https://www.wikidata.org/wiki/Q918036","display_name":"Race (biology)","level":2,"score":0.32710000872612},{"id":"https://openalex.org/C56273599","wikidata":"https://www.wikidata.org/wiki/Q3122841","display_name":"White (mutation)","level":3,"score":0.3188000023365021},{"id":"https://openalex.org/C120821319","wikidata":"https://www.wikidata.org/wiki/Q1501491","display_name":"Copy-number variation","level":4,"score":0.2921999990940094},{"id":"https://openalex.org/C2987028688","wikidata":"https://www.wikidata.org/wiki/Q49085","display_name":"African american","level":2,"score":0.28690001368522644},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.26649999618530273},{"id":"https://openalex.org/C37463918","wikidata":"https://www.wikidata.org/wiki/Q387981","display_name":"Allele frequency","level":4,"score":0.2637999951839447},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.25679999589920044}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.sabcs25-ps4-01-11","doi":"https://doi.org/10.1158/1557-3265.sabcs25-ps4-01-11","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs25-ps4-01-11","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"},{"score":0.7578999996185303,"display_name":"Reduced inequalities","id":"https://metadata.un.org/sdg/10"}],"sustainable_development_goals_aurora":[{"score":0.8492791056632996,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Black":[2,61,143,226,242,259,278,328],"patients":[3],"(pts)":[4],"are":[5],"more":[6,253,307],"likely":[7],"to":[8,24,195,200,420],"be":[9],"diagnosed":[10],"with":[11,74,115,133,250,269,280,322,330,334,338],"mBC":[12,116,401],"and":[13,35,41,56,80,94,105,111,117,138,144,161,181,183,204,228,283,294,354,383,417,461,468],"have":[14,47],"higher":[15,29],"mortality":[16],"rates":[17,30,150],"than":[18],"White":[19,50,145,230,248,302],"pts,":[20,260,390],"in":[21,60,72,91,208,265,318,376,414,454,470],"part":[22],"due":[23],"social":[25],"determinants":[26],"of":[27,31,58,164,370,397,411,451,456,478],"health,":[28],"de":[32],"novo":[33],"mBC,":[34],"possible":[36],"genomic":[37,135,415],"differences":[38,70,90,375,399,453],"by":[39,97,107,153,157,187,211,271,324],"race":[40,108,139,272,325],"ethnicity.":[42],"Most":[43],"variant":[44],"classification":[45],"efforts":[46],"focused":[48],"on":[49,400],"populations,":[51],"creating":[52],"uncertainty":[53],"about":[54],"prevalence":[55],"significance":[57,458],"VUS":[59,149,235,377],"pts.":[62],"It":[63],"is":[64],"also":[65,304],"unclear":[66],"if":[67],"mutation":[68,463],"frequency":[69,236],"exist":[71],"genes":[73],"known":[75,422],"targets,":[76],"such":[77],"as":[78,155],"PIK3CA":[79,95,162,171,308,312,331,462],"ESR1.":[81],"We":[82],"examined":[83],"a":[84,371],"real-world":[85],"(rw)":[86],"database":[87],"for":[88,109,273,394,408],"racial":[89,452],"VUS,":[92],"ESR1":[93,110,160,251,256,274,281,460],"detected":[96],"circulating":[98],"tumor":[99],"DNA":[100],"(ctDNA),":[101],"matched":[102,266,319,380,465],"therapy":[103,178,267,320,381,466],"use,":[104,382,467],"outcomes":[106,184,384,469],"PIK3CA.":[112],"Methods:":[113],"Pts":[114],"ctDNA":[118],"(Guardant360)":[119],"results":[120],"post-mBC":[121],"diagnosis":[122],"were":[123,151,185,190,224,385],"identified":[124],"from":[125],"Guardant":[126],"INFORM":[127],"(n=46,286),":[128],"which":[129],"includes":[130],"de-identified":[131],"records":[132],"clinical":[134],"data,":[136],"claims,":[137],"when":[140],"available.":[141],"For":[142],"pts":[146,232,249,279,303,329,340],"(n=34,149),":[147],"overall":[148,205],"analyzed":[152],"race,":[154],"defined":[156],"OncoKB":[158],"annotation.":[159],"codons":[163],"interest":[165],"[ESR1":[166],"ligand":[167],"binding":[168],"domain":[169],"(LBDmut);":[170],"helical":[172],"or":[173],"kinase":[174],"domains":[175],"(HKmut)],":[176],"targeted":[177],"matching":[179],"(elacestrant":[180],"alpelisib),":[182],"evaluated":[186],"race.":[188,212],"Outcomes":[189],"assessed":[191],"using":[192],"rw":[193,368],"time":[194,199],"treatment":[196,202],"discontinuation":[197],"(rwTTD),":[198],"next":[201],"(rwTTNT),":[203],"survival":[206],"(rwOS)":[207],"months,":[209],"stratified":[210],"Chi-squared":[213],"tests":[214,218],"compared":[215,219,337],"proportions;":[216],"log-rank":[217],"time-to-event":[220],"outcomes.":[221,402],"Results:":[222],"There":[223],"12.5%":[225],"(5,791/46,286)":[227],"61.2%":[229],"(28,358/46,286)":[231],"included.":[233],"Mean":[234],"was":[237,262,315],"similar":[238],"between":[239,388],"groups":[240],"(2.40":[241],"vs":[243,258,291,299,346,351,357],"2.47":[244],"White,":[245],"p>0.05).":[246],"While":[247],"mutations":[252],"frequently":[254],"had":[255,286,305,341],"LBDmut":[257,275,282],"there":[261,314],"no":[263,316],"difference":[264,317],"use":[268,321],"elacestrant":[270,285],"(Table":[276,326],"1).":[277,327],"2L":[284,335],"significantly":[287,306],"shorter":[288,295],"rwTTD":[289,344],"(3.5":[290],"4.2,":[292],"p=0.024)":[293],"numeric":[296],"rwTTNT":[297,349],"(5.9":[298],"8.9,":[300],"p=0.32).":[301],"mutations,":[309],"yet":[310],"among":[311],"HKmut,":[313],"alpelisib":[323,336],"HKmut":[332],"treated":[333],"white":[339],"numerically":[342],"longer":[343],"(4.4":[345],"3.7,":[347],"p=0.48),":[348],"(8.7":[350],"6.6,":[352],"p=0.33),":[353],"rwOS":[355],"(33.9":[356],"25.9,":[358],"p=0.38);":[359],"none":[360],"reached":[361],"statistical":[362],"significance.":[363],"Conclusion:":[364],"In":[365],"this":[366],"large,":[367],"analysis":[369],"diverse":[372,412],"patient":[373],"population,":[374],"rate,":[378],"ESR1/PIK3CA":[379],"not":[386],"observed":[387],"Black/White":[389],"suggesting":[391],"the":[392,406,479],"need":[393,407],"additional":[395],"exploration":[396],"race-based":[398],"This":[403],"study":[404],"underscores":[405],"continued":[409],"inclusion":[410],"populations":[413],"discovery":[416],"prospective":[418],"studies":[419],"clarify":[421],"outcome":[423],"disparities.":[424],"Citation":[425],"Format:":[426],"A.":[427,428,440],"Davis,":[429],"L.":[430,435,448],"S.":[431],"Welch,":[432],"J.":[433],"Saha,":[434],"Bucheit,":[436],"M.":[437,445],"D.":[438],"Lipsyc-Sharf,":[439],"Bardia,":[441],"C.":[442],"X.":[443],"Ma,":[444],"Cristofanilli,":[446],"E.":[447],"Podany.":[449],"Exploration":[450],"variants":[455],"uncertain":[457],"(VUS),":[459],"frequency,":[464],"metastatic":[471],"breast":[472],"cancer":[473],"(mBC)":[474],"[abstract].":[475],"In:":[476],"Proceedings":[477],"San":[480,489],"Antonio":[481],"Breast":[482],"Cancer":[483,496],"Symposium":[484],"2025;":[485],"2025":[486],"Dec":[487],"9-12;":[488],"Antonio,":[490],"TX.":[491],"Philadelphia":[492],"(PA):":[493],"AACR;":[494],"Clin":[495],"Res":[497],"2026;32(4":[498],"Suppl):Abstract":[499],"nr":[500],"PS4-01-11.":[501]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2026-02-18T00:00:00"}